BIOTECHNOLOGY VALUE FUND L P - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...13, 14, 15, 16, 17
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-04-28
09:26 am
Purchase
2021-04-2313DRAIN ONCOLOGY INC.
RAIN
BIOTECHNOLOGY VALUE FUND L P1,852,511
13.000%
1,852,511increase
(New Position)
Filing
History
2021-04-15
4:11 pm
Purchase
2021-04-1313GOVID THERAPEUTICS INC
OVID
BIOTECHNOLOGY VALUE FUND L P6,631,051
10.100%
2,109,000increase
(+46.64%)
Filing
History
2021-04-15
4:06 pm
Purchase
2021-04-1313GCONTRAFECT CORP COM
CFRX
BIOTECHNOLOGY VALUE FUND L P49,654
10.100%
13,293increase
(+36.56%)
Filing
History
Goto Prev, 0, 1, ...13, 14, 15, 16, 17